Last reviewed · How we verify
NCT06766292
Osteogenic Potential of Schneiderian Membrane
NA trial testing primary intervention in Bone Healing in 14 participants. Completed in 3 September 2024.
3 August 2024
Quick facts
| Lead sponsor | rehab soliman |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 27 August 2023 |
| Primary completion | 3 August 2024 |
| Estimated completion | 3 September 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- primary intervention
- open sinus lifting with xenograft only
Conditions studied
- Bone Healing — all drugs for Bone Healing →
- Sinus Membrane Osteoginicity — all drugs for Sinus Membrane Osteoginicity →
Sponsor
rehab soliman
Who can join
Adults 25 to 55, any sex, with Bone Healing or Sinus Membrane Osteoginicity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Maxillary sinus augmentation is commonly performed by creating a space below the Schneiderian membrane which is further filled using autografts, bone graft substitutes, or a combination of both to allow for new bone formation. Recently, a new method called non-grafting sinus floor augmentation has been introduced as an alternative approach. This method is based on the idea of elevating the membrane and supporting it through implant insertion or the use of space-maintaining devices like titanium screws or mesh. This study was conducted to evaluate the efficacy of new bone formation after sinus floor elevation using space maintaining resorbable pins without graft material.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Clinical, radiographic and histomorphometry evaluation of the osteogenic potential of Schneiderian membrane after graftless maxillary sinus augmentation: a randomized controlled clinical trial.
ElSholkamy M, Mokhtar RH, Eltayeb TM, Helwa I, et al · · 2026 · PMID 41715114 · DOI 10.1186/s12903-026-07772-2
Verify or expand the search:
- PubMed search for NCT06766292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Healing
Currently open trials in the same condition.
- NCT06624982 — Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation · recruiting
- NCT06711744 — ISQ Differences Between Different Implants in Post-extraction Sockets · NA · recruiting
- NCT07190950 — Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction · NA · recruiting
Other rehab soliman trials
Trials by the same sponsor.
- NCT06736821 — Maxillary Sinus Augmentation by Xenograft Mixed With Melatonin · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06766292 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by rehab soliman
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing